text:
Over two-thirds of the world's population lives in regions where rabies is endemic, resulting in over 15 million people receiving multi-dose post-exposure prophylaxis (PEP) and over 55,000 deaths per year globally. A major goal in rabies virus (RABV) research is to develop a single-dose PEP that would simplify vaccination protocols, reduce costs associated with RABV prevention, and save lives. Protection against RABV infections requires virus neutralizing antibodies; however, factors influencing the development of protective RABV-specific B cell responses remain to be elucidated. Here we used a mouse model of IL-21 receptor-deficiency (IL-21R−/−) to characterize the role for IL-21 in RABV vaccine-induced immunity. IL-21R−/− mice immunized with a low dose of a live recombinant RABV-based vaccine (rRABV) produced only low levels of primary or secondary anti-RABV antibody response while wild-type mice developed potent anti-RABV antibodies. Furthermore, IL-21R−/− mice immunized with low-dose rRABV were only minimally protected against pathogenic RABV challenge, while all wild-type mice survived challenge, indicating that IL-21R signaling is required for antibody production in response to low-dose RABV-based vaccination. IL-21R−/− mice immunized with a higher dose of vaccine produced suboptimal anti-RABV primary antibody responses, but showed potent secondary antibodies and protection similar to wild-type mice upon challenge with pathogenic RABV, indicating that IL-21 is dispensable for secondary antibody responses to live RABV-based vaccines when a primary response develops. Furthermore, we show that IL-21 is dispensable for the generation of Tfh cells and memory B cells in the draining lymph nodes of immunized mice but is required for the detection of optimal GC B cells or plasma cells in the lymph node or bone marrow, respectively, in a vaccine dose-dependent manner. Collectively, our preliminary data show that IL-21 is critical for the development of optimal vaccine-induced primary but not secondary antibody responses against RABV infections.
Author Summary
Over two-thirds of the world's population lives in regions where rabies is endemic, resulting in over 15 million people receiving post-exposure treatment. A person, disproportionately a child, dies of rabies every 20 minutes and the cost of rabies prevention exceeds $1 billion US dollars per year. The development of a single-dose human rabies vaccine would greatly reduce the burden of rabies globally by lowering the cost associated with rabies vaccination and saving lives. Understanding how B cells develop to produce protective virus neutralizing antibodies would greatly help to achieve the goal of developing a single-dose vaccine. In this report, we show that IL-21 is critical for the induction of primary vaccine-induced anti-RABV G antibody titers and that the effects of IL-21 are highly dependent on the dose of vaccine administered. In our model of rabies immunogenicity and protection, the lack of IL-21 receptor influenced the detection of B cells in germinal centers in lymph nodes or of plasma cells in bone marrow after immunization with low or high doses of vaccine, respectively. Overall, these preliminary results indicate that IL-21 has the potential to influence B cell development and functions in the context of rabies vaccine-induced immunity and protection.
Citation: Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP (2013) Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity. PLoS Negl Trop Dis 7(3): e2129. doi:10.1371/journal.pntd.0002129
Editor: Hechmi Louzir, Institut Pasteur de Tunis, Tunisia
Received: October 16, 2012; Accepted: February 8, 2013; Published: March 14, 2013
Copyright: © 2013 Dorfmeier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by NIH/NIAID grant R01AI079211 to JPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
RABV is a single-stranded negative sense RNA virus of the genus lyssavirus in the Rhabdoviridae family that kills approximately 55,000 people annually. Up to 60% of rabies cases are in children, making rabies the seventh most important infectious disease in terms of years lost [1]. In Africa, a person dies of rabies every 20 minutes [2]. In China, rabies became the leading cause of infectious disease mortality in 2006, which increased by more than 27% from 2005 [3]. In the United States, cases of rabies in wildlife are detected in virtually all states and Puerto Rico (Hawaii is considered rabies-free). Except for cattle and foxes, the incidence of rabies in domesticated or wildlife remained unchanged or significantly increased in the US in 2011 compared to the five-year average for each species [4], exemplifying the difficulty in containing zoonotic viral infections even in industrialized nations. The cost associated with rabies in the US, Africa and Asia is almost $1 billion annually [5], [6] contributing to the financial burden of global health care costs. Furthermore, rabies is a NIAID Category C Priority Pathogen, indicating rabies is an emerging infectious disease with the potential for mass dissemination and harm to people [7]. Together, rabies is considered a neglected global zoonotic infectious disease that disproportionately affects children and, therefore, understanding how B cells develop in response to experimental RABV-based vaccination may help to support efforts to develop a single-dose human rabies vaccine for use in both developing and industrialized countries.
A wide array of RABV variants exist, ranging from highly pathogenic strains to attenuated RABV vaccine strains such as the molecular clone SAD B19 [8]. Live attenuated RABV vaccine strains are highly immunogenic and potentially could serve as a single-dose human RABV vaccine to replace currently used multi-dose inactivated RABV-based vaccine regimens. Due to residual pathogenicity of these live virus strains, however, several "second-generation" RABV-based vaccines are under investigation in which entire genes are deleted from the RABV genome [9]–[12], or multiple pathogenic markers are genetically modified [13]. Data from these studies indicate that very safe and effective live RABV-based vaccine vectors can be generated. Despite extensive efforts to attenuate live RABV-based vaccine vectors for safety, little information is available on factors that influence the generation of effective antibodies in response to live RABV-based vaccines. Virus neutralizing antibodies (IgG but not IgM) directed against the RABV glycoprotein (G) are protective against pathogenic RABV strains [14], [15]. In the case of a replication-deficient RABV-based vaccine in which the matrix gene is deleted, VNAs are generated by T cell-independent and –dependent (extrafollicular and germinal center) mechanisms [16], suggesting multiple pathways of B cell activation and differentiation could be exploited to rationally design a single-dose RABV vaccine for use in both pre- and post-exposure settings. With respect to typical vaccine-induced antibody responses, APC-primed T cells most likely display an intermediate Tfh phenotype (i.e., "pre-Tfh cell") characterized phenotypically as CD4+CXCR5hiPD1lo, which migrate the T and B cell border of secondary lymphoid organs and interact with their cognate antigen-primed B cells [17]. This T∶B cell interaction typically results in the Tfh cells producing optimal amounts of IL-21, and in the B cells differentiating into early short-lived extrafollicular antibody secreting cells or migrating into the follicles and forming GCs. With additional signals provided by Tfh cells in GCs, B cells mature and differentiate into long-lived plasma cells (PCs) secreting high affinity antibodies or into memory B cells. Due to the importance for PCs secreting high affinity antibodies and memory B cells in vaccine-induced immunity, the development of Tfh cells and CG B cells is critical for vaccine-induced protection against future exposures. In the context of RABV-specific vaccination in post-exposure settings, the rapid induction of extrafollicular B cell responses may also be critical to prevent infection of the CNS, especially in cases where treatment is delayed after exposure to a potentially infected animal. As such, understanding factors that generate short- and long-term anti-viral B cell responses will help design more efficacious RABV vaccines for use in humans.
Cytokines present at the time of antigen exposure influence T and B cell activation and GC formation and, therefore, also affect the outcome of vaccination. IL-21 [18], [19] is a type 1 cytokine that is a member of the common γ-chain receptor family, which also includes IL-2, IL-4, IL-7, IL-9, and IL-15. It is produced primarily by activated Tfh and Th17 cells and has pleiotropic effects throughout innate and adaptive immunity [reviewed in [20]]. The role for IL-21 in regulating Tfh and B cell functions was originally identified using model antigens [21]–[23]. In addition, the role for IL-21 in immunity and protection against helminth [24], viral [25], [26] and bacterial [22] infections has been studied. IL-21 is a key mediator for the control of persistent viral infections in mouse models of LCMV [27]–[29] and hepatitis B virus [30], or in humans infected with HIV [31]–[33] or HIV in combination with the 2009 H1N1 influenza virus vaccine [34]. However, the complexity and diversity of persistent infections makes it is difficult to pinpoint the effects of IL-21 on anti-viral B cells versus CD8+ T cells, both of which can contribute the control of many chronic infections [35]. Conversely, B cells play a critical role for clearance of most acute viral infections and for the efficacy of vaccines against most vaccine-preventable diseases. Clearance of RABV infections relies strictly on B cell-mediated effector functions, but not CD8+ T cells, for protection, making RABV infection an excellent mouse model to pinpoint the role for IL-21 in vaccine-induced immunity against RABV infections and potentially for other pathogens that rely solely on B cells for protection. In this report, our preliminary data indicate that IL-21 is critical for the development of effective vaccine-induced primary antibody responses against RABV infections by influencing GC B cells or PC generation in a vaccine dose-dependent manner, while also showing IL-21 is dispensable for RABV-specific secondary antibody responses when a primary antibody response develops.
Materials and Methods
Ethics statement
All animal work was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Jefferson Medical College, Thomas Jefferson University. Work was completed in accordance with international standards [Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)] and in compliance with Public Health Service Policy on Humane Care and Use of Laboratory Animals, The Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH).
Viral vaccine, challenge rabies virus and mice
The construction of the live RABV-based vaccine (rRABV) used in this study was described elsewhere and was previously named SPBN [9], [36], [37]. This vaccine is a molecular clone derived from the attenuated SAD-B19 vaccine strain of RABV. Virus stocks were propagated on baby hamster kidney cells and then concentrated and purified over a 20% sucrose cushion. The challenge virus used was the pathogenic Challenge Virus Strain-N2c (CVS-N2c), which is a mouse-adapted sublclone of CVS-21 RABV [38]. CVS-N2c was initially propagated in neonatal mouse brains and then passaged once in-vitro on a neuroblastoma cell line (NA cells). The titer of CVS-N2c required to kill unvaccinated mice was determined experimentally by inoculating serial ten-fold dilutions into naïve immune-competent mice [39] i.m. and then observing mice daily for clinical neurological symptoms of rabies. The titer required to kill unvaccinated mice within 8 days post-infection, which is typical for CVS-N2c [9], [10], was determined to be 105 focus forming units (ffu)/mouse. Cryopreserved embryos of mice deficient in the IL-21 receptor (B6;129-IL21r tm1Wjl/Mmucd); #015505-UCD) [39] were obtained from the Mutant Mouse Regional Resource Centers (NIH) and implanted and bred in-house at Thomas Jefferson University in a pathogen-free animal facility. Control C57BL/6 mice were obtained from the Frederick National Laboratory for Cancer Research (NCI).
The following antibodies where purchased from BD Biosciences, unless otherwise noted, and used for flow cytometry staining: APC-Cy7-B220 (clone RA3-6B2), PerCP-CY5.5-CXCR5 (clone 2G8), APC-CD138 (clone 281-2), PE-Cy7-CD95/Fas (clone Jo2), FITC-GL7, eFluor 450-CD4 (clone RM4–5, eBioscience), PE-PD1 (clone J43, eBioscience), Alexa Fluor 700-CD38 (clone 90, eBioscience), rat anti-mouse CD16/32 (FcBlock; Pharmingen).
Immunization, pathogenic challenges, sample collection and ELISA and virus neutralizing antibody assays to measure anti-RABV antibody titers
Groups of 6- to 10-week-old female IL-21R−/− or wild-type C57BL/6 mice were inoculated intramuscularly (i.m.) with 103 or 105 focus forming units (ffu)/mouse with rRABV or an equivalent volume of PBS as controls. Five weeks post-immunization, mice were challenged i.m. with 105 ffu/mouse with CVS-N2c and then observed for three weeks for clinical signs of rabies. Mice were euthanized at the onset of neurological symptoms. At various times post-immunization and challenge, blood was collected retro-orbitally. Three-fold serial dilutions of sera were tested by ELISA to determine RABV G-specific IgG antibodies as described [10] and reported as the reciprocal serial dilution. Data represented two independent experiments (N = 9–11 mice per group). To measure virus neutralizing antibody titers, the Rapid Fluorescent Foci Inhibition Test (RFFIT) was completed on pooled sera from two independent experiments as described previously [16], [40], [41].
Immunization, sample collection and flow cytometry analyses of T and B cell subsets from lymph nodes and bone marrow
Groups of 6- to 10-week-old female IL-21R−/− or wild-type mice were inoculated i.m. with 103 or 105 ffu/mouse with rRABV or PBS/naive as controls. Draining lymph nodes and bone marrow cells were collected 7 and/or 14 days post-immunization. Single cell suspensions (106 cells/sample) were incubated with rat anti-mouse CD16/32 (1 ug/106 cells) in fluorescence-activated cell sorter (FACS) buffer (PBS supplemented with 2% fetal bovine serum) for 1 h on ice. Cells were washed twice with FACS buffer and incubated with fluorescently conjugated antibodies (0.2 ug/106 cells) for 30 min at RT in the dark. Cells were subsequently washed 2 times with FACS buffer and fixed in 2% paraformaldehyde in PBS for 30 minutes. Flow cytometry was completed using FACScan (BD LSRII) and analyzed by FlowJo software. Data represents samples completed in duplicate (N = 3–5 mice) [16].
Statistical analysis
Kaplan-Meier survival curves were analyzed by the log rank test; *p = <0.05 indicates significant survivorship between two immunization groups [9], [10]. Statistical difference between two groups of data was compared using an unpaired, two-tailed t test and data is presented at the mean ± SEM; *p<0.05, **p = 0.01–0.001, ***p≤0.001 [9], [10].
IL-21 is critical for primary but not secondary antibody responses to live RABV-based vaccination
Cytokines present at the time of immunization have the ability to affect the outcome of vaccine-induced B cell responses. Due to the importance for IL-21 in promoting effective T-dependent B cell responses [21], [22], we examined the requirement for IL-21R signaling in the generation of antibodies in a mouse model of RABV immunogenicity and protection using a mouse model of IL-21R-deficiency. These mice, designated here as IL-21R−/− mice, lack the IL-21R extracellular and transmembrane domains but show normal lymphoid development [39]. T and B cells exhibit similar proliferative responses to CD3-speficic antibodies or LPS, respectively, when compared to wild-type controls [39]. As a group, IL-21R−/− mice immunized with a low dose of a live recombinant RABV-based vaccine (rRABV) (103 ffu/mouse) showed only low levels of anti-RABV G antibodies that were not significantly different from PBS-immunized mice at all time points tested post-immunization (Figure 1, left panels, a–e), although at least three IL-21R−/− mice developed anti-RABV antibodies by day 28 post-immunization (Figure 1B). The seroconversion of these three IL-21−/− mice may explain the limited protection observed in the pathogenic challenge experiments described later in this report. Wild-type mice immunized with the same dose of rRABV showed significant levels of anti-RABV G antibodies as early as 7 days post-inoculation compared to rRABV-immunized IL-21R−/− mice, and these antibody responses continued to increase through day 21 post-immunization. VNA titers detected 28 days post-immunization (Figure 1C) are consistent with the antibody titers detected by ELISA (Figure 1B) indicating anti-RV antibody titers detected by ELISA are representative of the ability for vaccine-induced antibodies to neutralize rabies virus. IL-21R−/− mice immunized with a higher dose of rRABV (105 ffu/mouse) showed significantly reduced anti-RABV antibody responses when compared to wild-type mice also immunized with 105 ffu/mouse of rRABV (Figure 1, right panels, f–j). Together, this data indicates that IL-21 is critical for the induction of optimal primary anti-RABV antibody responses, especially when low doses of vaccine are used.
A) IL-21R−/− or wild-type C57BL/6 mice were immunized i.m. with 103 (left panels a–e) or 105 (right panels f–j) ffu/mouse of rRABV and blood collected at the indicated time points. Four serial three-fold dilutions of sera were analyzed by ELISA to determine anti-RABV G antibody titers and presented as OD490 of the reciprocal serial dilution. For comparison, sera from PBS-immunized IL-21R−/− or wild-type mice (panel k) were tested in parallel and representative ELISA data for day 21 post-immunization is shown. B) Antibody titers for individual mice immunized with 103 ffu/mouse [from Figure 1A(e)] are shown to indicate that at least three of the ten IL-21R−/− mice seroconverted against RABV G by day 28 post-immunization. C) VNA titers were measured from pooled sera collected 28 days post-immunization by RFFIT and expressed as International Units (IU/ml). The average of two independent experiments is shown. Statistical difference in antibody titers by ELISA between two groups of data was determined using an unpaired, two-tailed t test and data is presented at the mean ± SEM. *p<0.05, **p = 0.01–0.001, ***p≤0.001. (N = 9–11 mice per group from two independent experiments). (ffu = focus forming units; OD = optical density).
We next wanted to evaluate the effect of IL-21 on vaccine-induced antibody recall responses and protection against pathogenic RABV challenge. Five weeks post-immunization with rRABV, mice from Figure 1 were challenged with 105 ffu/mouse of a highly pathogenic mouse-adapted RABV strain (Challenge Virus Strain-N2c; CVS-N2c) [38], which typically kills naïve mice within 8 days post-infection [9], [10]. Consistent with the low antibody titers detected during the primary antibody response, significantly less anti-RABV antibodies were detected three or five days post-challenge in IL21R−/− mice immunized with 103 ffu/mouse of rRABV compared to the antibody recall response detected in wild-type mice (Figure 2, panels a and b, and Figure 2B) and antibody recall titers were not significantly different from PBS-immunized/CVS-N2c-challenged mice (Figure 2, e). Only 40% of IL-21R−/− mice immunized with 103 ffu/mouse of rRABV were protected against pathogenic RABV challenge, while all wild-type mice that were similarly immunized were protected against challenge (Figure 3, left panel). As expected, those mice with higher antibody titers showed protection compared to mice with lower antibody titers (Figure 2B). Conversely, an antibody recall response was induced in IL-21R−/− mice immunized with 105 ffu/mouse of rRABV within three days post-challenge with CVS-N2c at levels equivalent to rRABV-immunized wild-type mice (Figure 2, panels c and d) and all immunized IL-21R−/− mice were protected against pathogenic RABV challenge (Figure 3, right panel). Taken together, IL-21 is required for optimal primary (Figure 1) but not secondary (Figure 2) antibody responses to RABV vaccination. Furthermore, IL-21 is required for protection against pathogenic RABV in a vaccine dose-dependent manner (Figure 3).
A) Five weeks post-immunization, mice immunized in Figure 1 with 103 (left panels a and b) or 105 (right panels c and d) ffu/mouse were challenged with 105 ffu/mouse of pathogenic Challenge Virus Strain-N2c and sera analyzed 3 and 5 days post-challenge by ELISA for anti-RABV G antibody recall responses as described in Figure 1. PBS-immunized IL-21R−/− and wild-type mice were also tested in parallel and a representative ELISA data is shown in panel e. B) Antibody titers for individual mice immunized with 103 ffu/mouse rRABV and then challenged [from Figure 2A(b)] are shown to indicate an antibody recall response against RABV G by day 3 post-challenge in a minimum number of IL-21R−/− mice. Mice that survived challenged are shown with a green icon, mice that did not survive challenge are shown with a red icon. Statistical difference in antibody titers by ELISA between two groups of data was determined using an unpaired, two-tailed t test and data is presented at the mean ± SEM. *p<0.05, **p = 0.01–0.001, ***p≤0.001. (N = 9–11 mice per group from two independent experiments). (p.c. = post-challenge; ffu = focus forming units; OD = optical density).
Immunized (Figure 1) and challenged (Figure 2) mice were monitored daily for 28 days post-challenge for clinical signs of rabies and euthanized at the first neurological symptoms of RABV infection (103 ffu/mouse left panel; 105 ffu/mouse, right panel). Kaplan-Meier survival curves were analyzed by the log rank test; *p<0.05. (N = 9–11 mice per group from two independent experiments). (ffu = focus forming units).
IL-21 is dispensable for Tfh formation at all vaccine doses tested but required for optimal GC B cells in a vaccine dose-dependent manner
Next we wanted to determine whether the impaired primary anti-RABV antibody response in IL-21R−/− mice was due to an overall defect in the generation of Tfh and/or GC B cells. Lymph nodes from IL-21R−/− or wild-type mice were collected 7 or 14 days post-immunization with 103 or 105 ffu/mouse of rRABV or PBS alone to determine the influence of IL-21 on Tfh and B cell populations. Representative gating strategies [17], [42] to identify CD4+ T cells from the total live lymph node cultures (Figure 4A) or Tfh (CD4+CXCR5hiPD1hi) cells from the CD4+ T cell populations (Figure 4B) are shown. A significant increase in the number of CD4+ T cells displaying a Tfh phenotype was detected in IL-21R−/− mice 14 days post-immunization with 103 or 105 ffu/mouse rRABV compared to similarly immunized wild-type mice (Figure 4C and Figure 4D, respectively). However, the formation of optimal GC B cells appears to be dependent on the dose of vaccine administered (Figure 5). Representative gating strategies [22], [43], [44] to identify B220+ B cells from the total live lymph node cultures (Figure 5A) or GC B cells (B220+GL7hiCD95/Fashi) from the B220+ B cell population (Figure 5B) are shown. IL-21R−/− mice immunized with a low dose of vaccine failed to induce optimal GC B cell formation compared to wild-type mice 14 days post-immunization, as shown by a significant decrease in the number of GC B cells in IL-21R−/− mice compared to wild-type mice (Figure 5C). However, a significant increase in the number of GC B cells was detected in IL-21R−/− mice immunized with 105 ffu/mouse of rRABV compared to wild-type mice 14 days post-immunization (Figure 5D). The data indicates that the suboptimal primary antibody responses detected in IL-21R−/− mice immunized with 103 ffu/mouse of rRABV appears to be due to the lack of GC B cell formation, while the suboptimal primary antibody response detected in IL-21R−/− mice immunized with 105 ffu/mouse most likely does not result from a defect in Tfh or GC B cell development.
IL-21R−/− or C57BL/6 mice were immunized i.m. with a single dose of 103 or 105 ffu/mouse with rRABV and Tfh cell development was analyzed at the indicated time points post-immunization. A, Representative gating strategy from IL-21R−/− or C57BL/6 mice immunized with rRABV or an equal volume of PBS as a control to identify CD4+ T cells from total live draining lymph node cells. B, Representative gating strategy from IL-21R−/− or wild-type mice immunized with rRABV or PBS to identify Tfh (CD4+CXCR5hiPD1hi) cells from the CD4+ T cell population. C and D, Percentage of Tfh cells in the total CD4+ T cell population in lymph nodes was determined in IL-21R−/− or C57BL/6 mice 7 and 14 days post-immunization with 103 (C) or 105 (D) ffu/mouse rRABV or PBS. Statistical difference in T cell data between two groups of data was determined using an unpaired, two-tailed t test and data is presented at the mean ± SEM. *p<0.05, **p = 0.01–0.001, ***p≤0.001; (N = 5 mice per group).
Draining lymph node cells from IL-21R−/− or wild-type C57BL/6 mice immunized in Figure 4 were analyzed for the presence of B cells displaying a GC phenotype (B220+GL7hiCD95/Fashi). A, Representative gating strategy from IL-21R−/− or C57BL/6 mice immunized with rRABV or PBS to identify B220+ B cells from total live lymph node cells. B, Representative gating strategy from IL-21R−/− or wild-type mice immunized with rRABV or PBS to identify GC B cells. C and D, Number of GC B cells per 100,000 draining lymph node cells was determined in IL-21R−/− or wild-type mice immunized with 103 (C) or 105 (D) ffu/mouse 7 or 14 days post-immunization with rRABV or PBS alone. Statistical difference in GC B cell data between two groups of data was determined using an unpaired, two-tailed t test and data is presented at the mean ± SEM. *p<0.05, **p = 0.01–0.001, ***p≤0.001; (N = 5 mice per group); (ffu = focus forming units).
IL-21 is dispensable for memory B cells formation but required for plasma cell generation in response to live RABV-based vaccination
Our analysis above shows that IL-21R signaling is dispensable for the formation of the Tfh and GC B cell populations in response to higher doses of rRABV, indicating that other B cell types are more likely responsible for the suboptimal primary antibody titers detected in IL-21R−/− mice immunized with 105 ffu/mouse. Since IL-21 can also influence the balance between the generation of memory B cells and PCs [24], [45]–[47], we investigated the role for IL-21R signaling to regulate memory B cell and PCs populations in response to RABV vaccination. Figure 6A and Figure 6B show representative gating strategies [48]–[50] to identify the memory B220+ B cells (CD38+CD138−) from the lymph node and PC (B220loCD138+) populations from the bone marrow from mice immunized with 103 or 105 ffu/mouse of rRABV or PBS alone. The presence or absence of IL-21R does not appear to influence the development of memory B cells in mice immunized with 103 ffu/mouse of rRABV (Figure 6C). However, the percentage of memory B cells was significantly increased in the lymph node cell cultures from IL-21R−/− mice immunized with 105 ffu/mouse of rRABV as early as 7 days post-immunization compared to immunized wild-type mice (Figure 6C). By day 14 post-immunization, similar memory B cell populations were measured (data not shown), indicating that IL-21 is not required for the formation of memory B cells in response to live RABV-based vaccination. This is consistent with the findings in Figure 1 and Figure 2 indicating that IL-21 is dispensable for secondary antibody responses against RABV infection when a primary antibody response develops. However, the percentage of PCs was reduced in the bone marrow of IL-21R−/− mice immunized with 105 ffu/mouse compared to rRABV- or PBS-immunized wild-type mice 14 days post-immunization (Figure 6D), consistent with the suboptimal primary antibody titers detected in IL-21R−/− mice.
IL-21R−/− or C57BL/6 mice were immunized i.m. with a single dose of 103 or 105 ffu/mouse with rRABV and memory B cell or PC populations were analyzed 7 or 14 days post-immunization, respectively. A, B220+ B cells were gated from the total live draining lymph node cell population as described in Figure 5. Representative gating strategy from IL-21R−/− or C57BL/6 mice immunized with rRABV or PBS to determine memory B cells (B220+CD38+CD138−) from total B220+ B cells in the draining lymph node. B, Representative gating strategy from IL-21R−/− or C57BL/6 mice immunized with rRABV or PBS to identify PCs (B220loCD138+) from the total cells in the bone marrow. C, Percentage of B cells displaying a memory B cell phenotype in the lymph node was determined in IL-21R−/− or C57BL/6 mice immunized with 103 or 105 ffu/mouse at 7 days post-immunization with rRABV or PBS. D, Percentage of PCs in the BM cell population was determined from IL-21R−/− or C57BL/6 mice immunized with 103 or 105 ffu/mouse at 14 days post-immunization with rRABV or PBS. Statistical difference in B cell data between two groups of data was determined using an unpaired, two-tailed t test and data is presented at the mean ± SEM. *p<0.05, **p = 0.01–0.001, ***p≤0.001; (N = 5 mice per group).
Current rabies PEP regimens are based on multiple doses of inactivated RABV-based vaccines administered intramuscularly or intradermally. In cases of severe exposure, rabies immune globulin (RIG) is administered [51]–[53]. The development of a single-dose vaccine would greatly benefit human rabies prevention by reducing the cost of vaccination and saving lives. Understanding immune parameters that influence the magnitude and/or quality of anti-RABV antibody responses may lead to more effective single-dose vaccines [54]. Correlates of protection against rabies infections are defined as virus neutralizing antibodies directed against the single viral transmembrane glycoprotein (G) [15], [52], [54], [55]. CD8+ T cells do not appear to be important for the clearance of RABV infections [56]. Protection against RABV infection typically requires CD4+ T cell help [56]–[60], although we recently showed that this requirement is not absolute and that protection against pathogenic RABV challenge can be afforded in mice devoid of all T cells (TCRβδ−/− mice) vaccinated with a matrix gene-deleted RABV-based vaccine (rRABV-ΔM) [16]. Furthermore, we show that mice immunized with rRABV-ΔM also induce antibodies by T cell-dependent extrafollicular B cell responses before GC-derived B cells are detected. Together, our previous work identified multiple pathways of B cell development that can be exploited to make more efficacious RABV-based vaccines for use in humans. Nonetheless, very little information is available on how effective B cells develop in response to live RABV-based vaccination. IL-21 is a pleotropic cytokine that is produced by NKT cells and CD4+ T cells, most notably Th17 and Tfh cells. IL-21 binds to the IL-21R on a wide variety of cells involved in innate immunity, including DCs, NK cells, NKT cells, and macrophages, as well as on cells involved in adaptive immunity, such as B cells and CD4+ or CD8+ T cells [reviewed in [20]]. Due to its multiple roles in innate and adaptive immunity, IL-21 has the potential to influence the quality and magnitude of vaccine-induced immunity to acute viral infections. Here we used a mouse model of IL-21R-deficiency to evaluate the role for IL-21R signaling in vaccine-induced protection against RABV; i.e., an acute viral infection that relies on B cells for protection that has implications for global public health initiatives.
In this report, we showed that IL-21R signaling is critical for the generation of optimal primary anti-RABV antibody responses to vaccination. Primary anti-RABV antibody titers were significantly reduced in immunized IL-21R−/− mice compared to wild-type mice at almost all time points tested post-immunization, suggesting IL-21R signaling plays important roles throughout RABV-specific primary B cell responses. Nonetheless, IL-21R signaling appears to influence immunity in a vaccine dose-dependent manner, which is consistent with findings by others suggesting the influence of IL-21 is dependent on the model studied [22], [61]. Indeed, significantly less IL-21R−/− mice immunized with low-dose vaccination were protected against pathogenic challenge compared to wild-type mice while all IL-21R−/− and wild-type mice immunized with high-doses of vaccine survived challenge similarly. Despite the differences in protection elicited in IL-21R−/− mice immunized with different doses of vaccine, it appears that IL-21 is critical for the generation of optimal RABV-specific primary B cell responses.
One potential explanation for the suboptimal primary antibody responses observed in immunized IL-21R−/− mice compared to immunized wild-type mice might be that GC B cells failed to form in IL-21R−/− mice, therefore, the GC B cell compartment was analyzed in mice immunized with different doses of vaccine. GC-derived B cells were reduced in IL-21R−/− mice immunized with a low dose of vaccine compared to similarly immunized wild-type mice, indicating that IL-21 is required for optimal GC B cell formation in response to low-dose RABV-based vaccination. On the other hand, GC-derived B cells expanded in IL-21R−/− mice immunized with a high dose of vaccine compared to similarly immunized wild-type mice, indicating that IL-21 is dispensable for GC B cell formation after high-dose vaccination with rRABV-based vaccines. Furthermore, the data indicates that factors other than IL-21 were responsible for GC B cell formation in IL21R−/− mice immunized with higher doses of vaccine. Multiple signals lead to B cell activation and functions. These signals can come from BCR or Toll-like receptor (TLR) ligation, TNF superfamily receptor engagement (eg., via BAFF and APRIL) or cytokine signaling. Furthermore, B cell activation is contextual, meaning B cells are differentially activated in the presence of different signals at the time of antigen exposure. Due to the repetitive display of rabies antigen on the surface of infectious particles, the potential exists that cross-linking BCRs and/or TLRs on the surface of B cells overcame the requirement for IL-21R signaling in B cell activation when high doses of vaccine are administered. The influences of these and other B cell signaling events in the context of RABV-based vaccine-induced B cell activation were not directly measured in these studies and remain to be elucidated. Nonetheless, based on the results reported here, it appears that IL-21R signaling is important for optimal primary vaccine-induced antibody responses to RABV vaccination especially when low doses of vaccine are administered.
As noted above, a rapid antibody response is critical for rabies PEP to neutralize virus before it reaches the CNS. We have recently shown that RABV-based vaccines are able to induce early and rapid T cell-dependent extrafollicular antibody responses before GC B cells are formed [16]. These early pre-GC B cell responses contributed to the protection against pathogenic RV challenge early post-immunization, which is an important attribute for PEP [16]. In the studies described in this report, we detected a significant reduction in antibody titers in IL-21R−/− mice as early as 5 days post-immunization with a high dose of rRABV compared to immunized wild-type mice, suggesting that IL-21 may be influencing the outcome of extrafollicular antibody responses in the context of RABV vaccination, although this was not directly studied in this report. Nonetheless, the frequency of Tfh and GC B cells was similar in IL-21R−/− mice compared to wild-type mice 7 days post-immunization and, therefore, it would appear that the early suboptimal antibody responses in IL-21R−/− mice may be due to impaired extrafollicular PCs directly and not through impaired Tfh or GC B cell formation. This is consistent with the findings that IL-21 can promote Blimp-1 expression and PC development [47], IL-21- or IL-21R-deficiency decreases extrafollicular PCs in a model of NP-KLH immunity [62], and that IL-21 acts on early stages of B cell differentiation before GC or PC B cells are formed [42]. Finally, IL-21 has been reported to be important for Tfh cell maintenance but not formation. Together, existing data suggests that IL-21R−/− signaling influences early events in pre-GC B cell development in the context of RABV vaccination [22].
IL-21 can also influence the balance of B cell differentiation into memory B cells or PCs [45]–[47]. The specific role for IL-21 in memory B cell responses is not completely clear and appears to rely on the type of antigen used and the model studied [61], [62]. In the context of RABV vaccination, IL-21R signaling was not required for the generation of B cells displaying a memory B cell phenotype in IL-21R−/− mice immunized with either vaccine dose. This is consistent with our finding showing that IL-21R signaling is not required for optimal secondary anti-RABV G antibody titers after challenge with pathogenic RABV. However, we detected a decrease in the number of PCs in IL-21R−/− mice immunized with either dose of vaccine compared to wild-type mice. We cannot determine whether the slightly suboptimal PC subset detected in IL-21R−/− mice immunized with low doses of vaccine was indirectly a result of impaired GC B cell development or directly as a result of impaired PC formation itself. However, in mice immunized with a high dose of vaccine where we observed an expansion of GC-derived B cells in IL-21R−/− mice, we also observed a decrease in PCs in the bone marrow compared to wild-type mice, indicating that IL-21 acts directly on the formation of PCs. Together, the data shows that IL-21 influences the balance between memory and PC B cell formation in the context of RABV vaccination.
Despite the impaired primary antibody response and PC B cell formation in immunized IL-21R−/− mice, we detected an expansion of CD4+ T cells displaying a pre-Tfh (data not shown), Tfh cell and GC B cell phenotype in IL-21R−/− mice compared to wild-type mice at 14 days post-immunization. The expansion of GC B cells and Tfh cells in the absence of IL-21R signaling was also shown by King I.L. et al in a model of Heligmosomoides polygyrus immunity [24], suggesting that IL-21R signaling may not be necessary for the generation of these cell types in response to a wide range of pathogens or vaccination. Furthermore, the increase in GC B cells and Tfh cells in H. polygyrus-infected or RABV-vaccinated IL-21R−/− mice suggests that IL-21R signaling may play an inhibitory role in the development of T and B cells in the context of some pathogens, which is consistent with the ability for IL-21 to activate or inhibit immune function depending on the antigen and available co-stimulatory signals [20]. The expansion of Tfh and GC B cells in IL-21R−/− mice compared to wild type mice is also consistent with the finding that IL-21 has the ability to mediate apoptosis in primary resting and activated murine B or to promote apoptosis or growth arrest for non-specifically activated B cells [63]. Alternatively, the elevated number of GC Tfh cells could be a result of the lack of PC that developed in the IL21R−/− mice. Pelletier et al described a negative regulatory feedback-loop in which antigen-specific PCs negatively regulate antigen-specific Tfh cell development and function [64]. In this report, they also observed a significant expansion of Tfh cells and GC B cells in the absence of PC development. Together, the role for IL-21 in the homeostatic balance of T and B cell development in the context of infectious diseases appears to be important and remains to be fully elucidated.
Additional studies are needed to identify the exact cell type(s) responsible for the affects described in this report. While we speculate that B cell-intrinsic IL-21R signaling is responsible for the induction of optimal anti-RABV antibody responses, we cannot rule out the influence of other cell types that also express IL-21R. IL-21 has the ability to influence the function of macrophages, NK cells and NKT cells by affecting survival/apoptosis, antigen processing, and cytokine secretion [reviewed in [20]]. The function of these cells of the innate immune system may indirectly be affecting the outcome of B or T cell functions in the context of RV vaccination. Nonetheless, IL-21 has the potential to influence a wide range of B cell functions and pathways. Our preliminary data indicates that IL-21 is critical for the formation of optimal vaccine-induced primary antibody responses and demonstrates an important role for IL-21 in the generation of vaccine-induced immunity against RABV infection and perhaps other acute infections that rely on B cell-mediated effector functions for protection.
We would like to thank the Mutant Mouse Regional Resource Centers and Dr. Warren Leonard, M.D. for the IL-21R-deficient mouse strain (B6.129-Il21rtm1Wjl/Mmucd) and Dr. Carlisle Landel, Facility Director, Transgenic and Gene Targeting Facility, Kimmel Cancer Center, Thomas Jefferson University, for the recovery of the IL-21R−/− mice from cryopreserved embryos. We would also like to thank Matthew Farabaugh, Flow Cytometry Facility, Kimmel Cancer Center, Thomas Jefferson University for flow cytometry assistance.
Author Contributions
Conceived and designed the experiments: CLD JPM. Performed the experiments: CLD EPT AG. Analyzed the data: CLD EPT JPM. Contributed reagents/materials/analysis tools: JPM. Wrote the paper: JPM.
- 1. Jackson AC (2008) Rabies. Neurol Clin 26: 717–26. doi: 10.1016/j.ncl.2008.03.010
- 2. Dodet B, Africa Rabies Expert B, Adjogoua EV, Aguemon AR, Amadou OH, et al. (2008) Fighting rabies in africa: The africa rabies expert bureau (AfroREB). Vaccine 26: 6295–8. doi: 10.1016/j.vaccine.2008.04.087
- 3.
WHO (2007) Rabies and Envenomings: A neglected public health issue: Report of a Consultative Meeting. World Health Organization. 32 pp.
- 4. Blanton JD, Dyer J, McBrayer J, Rupprecht CE (2012) Rabies surveillance in the united states during 2011. J Am Vet Med Assoc 241: 712–722 10.2460/javma.241.6.712. doi: 10.2460/javma.241.6.712
- 5. Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, et al. (2005) Re-evaluating the burden of rabies in africa and asia. Bull World Health Organ 83: 360–8.
- 6.
CDC (2012) Cost of Rabies Prevention. Available: http://www.cdc.gov/rabies/location/usa/cost.html.
- 7.
NIAID (2012) NIAID Category A, B, and C Priority Pathogens. Available: http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/cata.aspx.
- 8. Conzelmann KK, Cox JH, Schneider LG, Thiel HJ (1990) Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175: 485–99. doi: 10.1016/0042-6822(90)90433-r
- 9. Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, et al. (2009) Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. Journal of Infectious Diseases 200: 1251–60. doi: 10.1086/605949
- 10. Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, et al. (2008) Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine 26: 6405–14. doi: 10.1016/j.vaccine.2008.08.069
- 11. Ito N, Sugiyama M, Yamada K, Shimizu K, Takayama-Ito M, et al. (2005) Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain. Microbiol Immunol 49: 971–9. doi: 10.1111/j.1348-0421.2005.tb03692.x
- 12. Morimoto K, Shoji Y, Inoue K (2005) Characterizatio of P gene-deficient rabies virus: Propagation, pathogenicity and antigenicity. Virus Research 111: 61–67. doi: 10.1016/j.virusres.2005.03.011
- 13. McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, et al. (2003) Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. Journal of Virology 77: 237–44. doi: 10.1128/jvi.77.1.237-244.2003
- 14. Johnson N, Cunningham AF, Fooks AR (2010) The immune response to rabies virus infection and vaccination. Vaccine 28: 3896–3901 10.1016/j.vaccine.2010.03.039. doi: 10.1016/j.vaccine.2010.03.039
- 15. Turner GS (1978) Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J Gen Virol 40: 595–604. doi: 10.1099/0022-1317-40-3-595
- 16. Dorfmeier CL, Lytle AG, Dunkel AL, Gatt A, McGettigan JP (2012) Protective vaccine-induced CD4+ T cell-independent B cell responses against rabies infection. J Virol 86: 11533–40 10.1128/JVI.00615-12. doi: 10.1128/jvi.00615-12
- 17. Goenka R, Barnett LG, Silver JS, O'Neill PJ, Hunter CA, et al. (2011) Cutting edge: Dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultimate effector differentiation. J Immunol 187: 1091–1095 10.4049/jimmunol.1100853. doi: 10.4049/jimmunol.1100853
- 18. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ (2000) Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A 97: 11439–11444 10.1073/pnas.200360997. doi: 10.1073/pnas.200360997
- 19. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, et al. (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57–63 10.1038/35040504.
- 20. Yi JS, Cox MA, Zajac AJ (2010) Interleukin-21: A multifunctional regulator of immunity to infections. Microbes Infect 12: 1111–1119 10.1016/j.micinf.2010.08.008. doi: 10.1016/j.micinf.2010.08.008
- 21. Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, et al. (2008) A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127–137 10.1016/j.immuni.2008.06.001. doi: 10.1016/j.immuni.2008.06.001
- 22. Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, et al. (2010) IL-21 acts directly on B cells to regulate bcl-6 expression and germinal center responses. J Exp Med 207: 353–363 10.1084/jem.20091738. doi: 10.1084/jem.20091738
- 23. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, et al. (2008) Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138–149 10.1016/j.immuni.2008.05.009. doi: 10.1016/j.immuni.2008.05.009
- 24. King IL, Mohrs K, Mohrs M (2010) A nonredundant role for IL-21 receptor signaling in plasma cell differentiation and protective type 2 immunity against gastrointestinal helminth infection. J Immunol 185: 6138–6145 10.4049/jimmunol.1001703. doi: 10.4049/jimmunol.1001703
- 25. Holm C, Nyvold CG, Paludan SR, Thomsen AR, Hokland M (2006) Interleukin-21 mRNA expression during virus infections. Cytokine 33: 41–45 10.1016/j.cyto.2005.11.014. doi: 10.1016/j.cyto.2005.11.014
- 26. Spolski R, Wang L, Wan CK, Bonville CA, Domachowske JB, et al. (2012) IL-21 promotes the pathologic immune response to pneumovirus infection. J Immunol 188: 1924–1932 10.4049/jimmunol.1100767. doi: 10.4049/jimmunol.1100767
- 27. Elsaesser H, Sauer K, Brooks DG (2009) IL-21 is required to control chronic viral infection. Science 324: 1569–1572 10.1126/science.1174182. doi: 10.1126/science.1174182
- 28. Frohlich A, Kisielow J, Schmitz I, Freigang S, Shamshiev AT, et al. (2009) IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324: 1576–1580 10.1126/science.1172815. doi: 10.1126/science.1172815
- 29. Yi JS, Du M, Zajac AJ (2009) A vital role for interleukin-21 in the control of a chronic viral infection. Science 324: 1572–1576 10.1126/science.1175194. doi: 10.1126/science.1175194
- 30. Publicover J, Goodsell A, Nishimura S, Vilarinho S, Wang ZE, et al. (2011) IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 121: 1154–1162 10.1172/JCI44198. doi: 10.1172/jci44198
- 31. Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, et al. (2010) IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication. J Leukoc Biol 87: 857–867 10.1189/jlb.1009701. doi: 10.1189/jlb.1009701
- 32. Iannello A, Allam O, Samarani S, Ahmad A (2012) Interleukin-21: A key cytokine for controlling HIV and other chronic viral infections. Med Sci (Paris) 28: 605–611 10.1051/medsci/2012286013. doi: 10.1051/medsci/2012286013
- 33. Ruffin N, Lantto R, Pensieroso S, Sammicheli S, Hejdeman B, et al. (2012) Immune activation and increased IL-21R expression are associated with the loss of memory B cells during HIV-1 infection. J Intern Med 272: 492–503 10.1111/j.1365-2796.2012.02550.x; 10.1111/j.1365-2796.2012.02550.x. doi: 10.1111/j.1365-2796.2012.02550.x
- 34. Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, et al. (2011) Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol 186: 6173–6181 10.4049/jimmunol.1100264. doi: 10.4049/jimmunol.1100264
- 35. McGavern DB (2010) A little 'help' from IL-21 during persistent viral infection. J Mol Cell Biol 2: 8–10 10.1093/jmcb/mjp021. doi: 10.1093/jmcb/mjp021
- 36. McGettigan JP, Naper K, Orenstein J, Koser M, McKenna PM, et al. (2003) Functional human immunodeficiency virus type 1 (HIV-1) gag-pol or HIV-1 gag-pol and env expressed from a single rhabdovirus-based vaccine vector genome. Journal of Virology 77: 10889–99. doi: 10.1128/jvi.77.20.10889-10899.2003
- 37. Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ (2000) A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proceedings of the National Academy of Sciences of the United States of America 97: 14680–5. doi: 10.1073/pnas.011510698
- 38. Morimoto K, Hooper DC, Carbaugh H, Fu ZF, Koprowski H, et al. (1998) Rabies virus quasispecies: Implications for pathogenesis. Proceedings of the National Academy of Sciences of the United States of America 95: 3152–6. doi: 10.1073/pnas.95.6.3152
- 39. Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, et al. (2002) A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630–1634 10.1126/science.1077002. doi: 10.1126/science.1077002
- 40. Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, et al. (2009) Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J Infect Dis 200: 1251–1260 10.1086/605949. doi: 10.1086/605949
- 41. Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, et al. (2008) Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine 26: 6405–6414 10.1016/j.vaccine.2008.08.069. doi: 10.1016/j.vaccine.2008.08.069
- 42. Lee SK, Rigby RJ, Zotos D, Tsai LM, Kawamoto S, et al. (2011) B cell priming for extrafollicular antibody responses requires bcl-6 expression by T cells. J Exp Med 208: 1377–1388 10.1084/jem.20102065. doi: 10.1084/jem.20102065
- 43. Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, et al. (2009) Follicular helper T cells are required for systemic autoimmunity. J Exp Med 206: 561–576 10.1084/jem.20081886. doi: 10.1084/jem.20081886
- 44. Linterman MA, Vinuesa CG (2010) T follicular helper cells during immunity and tolerance. Prog Mol Biol Transl Sci 92: 207–248 10.1016/S1877-1173(10)92009-7. doi: 10.1016/s1877-1173(10)92009-7
- 45. Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, et al. (2007) Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 179: 5886–5896.
- 46. Ettinger R, Sims GP, Fairhurst AM, Robbins R, da Silva YS, et al. (2005) IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175: 7867–7879.
- 47. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, et al. (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of blimp-1 and bcl-6. J Immunol 173: 5361–5371.
- 48. Metcalf TU, Griffin DE (2011) Alphavirus-induced encephalomyelitis: Antibody-secreting cells and viral clearance from the nervous system. J Virol 85: 11490–11501 10.1128/JVI.05379-11. doi: 10.1128/jvi.05379-11
- 49. Mathian A, Gallegos M, Pascual V, Banchereau J, Koutouzov S (2011) Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZBxNZW)F1 mice but not in BALB/c mice. Eur J Immunol 41: 863–872 10.1002/eji.201040649; 10.1002/eji.201040649. doi: 10.1002/eji.201040649
- 50. Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, et al. (2008) ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med 205: 2873–2886 10.1084/jem.20080840. doi: 10.1084/jem.20080840
- 51. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, et al. (2010) Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: Recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 59: 1–9. doi: 10.1016/j.annemergmed.2010.05.020
- 52.
WHO (1997) WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. World Health Organization. WHO/EMC/ZOO/96.6.
- 53.
WHO (2009) Current WHO guidelines for rabies pre- and post-exposure treatment in humans. World Health Organization.
- 54. McGettigan JP (2010) Experimental rabies vaccines for humans. Expert Rev Vaccines 9: 1177–1186 10.1586/erv.10.105. doi: 10.1586/erv.10.105
- 55. Plotkin SA (2008) Vaccines: Correlates of vaccine-induced immunity. Clin Infect Dis 47: 401–409 10.1086/589862. doi: 10.1086/589862
- 56. Perry LL, Lodmell DL (1991) Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J Virol 65: 3429–3434.
- 57. Bunschoten H, Dietzschold B, Claassen I, Klapmuts R, Uytdehaag F, et al. (1990) Rabies virus cross-reactive murine T cell clones: Analysis of helper and delayed-type hypersensitivity function. Viral Immunol 3: 41–53. doi: 10.1089/vim.1990.3.41
- 58.
Jackson AC, Wunner WH, editors (2007) Rabies. Elevier, Inc. 11–19 p.
- 59. Mifune K, Takeuchi E, Napiorkowski PA, Yamada A, Sakamoto K (1981) Essential role of T cells in the postexposure prophylaxis of rabies in mice. Microbiol Immunol 25: 895–904. doi: 10.1111/j.1348-0421.1981.tb00094.x
- 60. Turner GS (1976) Thymus dependence of rabies vaccine. J Gen Virol 33: 535–538. doi: 10.1099/0022-1317-33-3-535
- 61. Rankin AL, MacLeod H, Keegan S, Andreyeva T, Lowe L, et al. (2011) IL-21 receptor is critical for the development of memory B cell responses. J Immunol 186: 667–674 10.4049/jimmunol.0903207. doi: 10.4049/jimmunol.0903207
- 62. Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, et al. (2010) IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 207: 365–378 10.1084/jem.20091777. doi: 10.1084/jem.20091777
- 63. Jin H, Carrio R, Yu A, Malek TR (2004) Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or bim-dependent apoptosis. J Immunol 173: 657–665.
- 64. Pelletier N, McHeyzer-Williams LJ, Wong KA, Urich E, Fazilleau N, et al. (2010) Plasma cells negatively regulate the follicular helper T cell program. Nat Immunol 11: 1110–1118 10.1038/ni.1954; 10.1038/ni.1954. doi: 10.1038/ni.1954


text:
For more information about the site, see the
Site Index
Network security audit guidelines: Inside the importance of audit planning
Product review: ForeScout Technologies's ActiveScout 2.5
Microsoft's internal auditor discusses the company's IT security outlook
Microsoft security improving, while Trustworthy security lacks effort
Examining infosec hackers of the past and how they affect cybersecurity laws
Defining IT security resolutions
Hacking in 2003: Examining this year's hacking techniques
How to address enterprise IT security concerns with executives
Microsoft Security Response Center revamps its patch processes
SearchSecurity.com Blogs
Data security failure: How the government broke our trust
NetIQ's five-point security architecture
How to harden Windows to improve security
The IPv6 transition: How to ensure cybersecurity
Quiz: How DAM can help detect and trace attacks
Information security podcasts
RSA Conference 2011: News, interviews and updates
Looming IPv6 transition will strain federal cybersecurity
Information security tutorials
XML encryption and WS-Security tutorial: Essential elements of Web services security
XML firewall security guide: Prevent XML vulnerabilities and threats
Feds: Electronic health records privacy will require metadata scheme
Quiz: Building a compliance scorecard
About Us
Business partners
For Advertisers
Terms of Use
Federal electronic health records: Benefits and challenges abound
Secure VoIP tutorial: Understanding VoIP security best practices
Considering iPhone, iPad adoption? Take cybersecurity seriously
'Most wanted' security threats of 2010
Countdown: Top 5 ways to tune IDS/IPS to meet business needs
Quiz: How IDS/IPS can enable business objectives
CISSP practice quiz: Information security, enterprise risk management
PCI 2.0 guide: How have PCI compliance requirements changed?
Cybersecurity risk assessment: a basic framework
Federal cybersecurity needs better risk management
Cloud Security Alliance Congress
American Conference Institute - Privacy & Security of Consumer and Employee Information
InfoSecurity Russia. StorageExpo. Documation 2010
Fed's data center consolidation brings cybersecurity challenges
Desktop virtualization enhances telework security at CDC
Parade College adopts UTM for network security
Security policy for PDF use: How to secure PDF files for the enterprise
Quiz: Practical strategies to mitigate insider threats
Quiz: How to pass a PCI assessment
Symantec Vision 2010 – Get ready to take control
Cyber Security Readiness
Quiz: Database application security
Quiz: Application and network log management program planning
Smart grid security will require risk management
Smart grid system protection: SCADA security will challenge Feds
Black Hat conference 2010: News, podcasts and videos
VB2010 Vancouver
USB thumb drive security best practices spelled out by NIST
Making USB thumb drives secure enough for government work
Federal agencies scrambling on DNSSEC implementation
Web browser security tutorial: Safari, IE, Firefox browser protection
Fed DNSSEC project going slowly
OMG's CyberSecurity Forum
Government cyber security takes on more sophisticated attacks
Risk-based audit methodology: How to achieve enterprise security
Information Security Solutions Europe Conference (ISSE 2010)
Government security vulnerabilities: The threat of outsourced chips
IT security policy management: Effective polices to mitigate threats
For Federal IT, cloud savings not a slam dunk
Understanding tokenization amid PCI encryption requirements
RSA Conference 2010: news, interviews and updates
Mass 201 CMR 17: Basics for security practitioners
Screencasts: On-screen demonstrations of security tools
Securing your wireless network: Preventing wireless security threats
Quiz: Securing the application layer
Web application attacks security guide: Preventing attacks and flaws
Information security podcasts: 2009 archive
Fact or fiction: Inside extrusion detection and prevention technology
Quiz: Compliance-driven role management
PCI DSS compliance help: Using frameworks, technology to aid efforts
Quiz: How to build secure applications
Information Security Decisions 2009: Presentation downloads
Mini guide: How to remove and prevent Trojans, malware and spyware
Endpoint protection best practices manual: Combating issues, problems
Buffer overflow tutorial: How to find vulnerabilities, prevent attacks
SQL injection protection: A guide on how to prevent and stop attacks
Security book giveaway: Under-the-radar information security threats
Curveball: Endpoint encryption strategies
Quiz: Automated compliance in the enterprise
Managing third-party compliance
Information Security Learning Guides
Rogue AP containment methods
How to monitor WLAN performance with WIPS
Wireless Security Lunchtime Learning Final Exam
Lesson 4 quiz: How to use wireless IPS
Wireless intrusion prevention systems: Overlay vs. embedded sensors
Black Hat conference coverage 2009: News, podcasts and videos
How to prevent wireless DoS attacks
Wireless AP placement basics
The role of VPN in an enterprise wireless network
Quiz: Virtualization and compliance
Countdown: Top 5 issues involving data loss and the virtualized cloud
How to compartmentalize WiFi traffic with a VLAN

subset: commoncrawl


text:
Top 3 most effective supplements which
will help you to enlarge the bust size
Mother Nature has not given each of us the same gifts. Some of us were born tall, others short. The same is with breasts. Some girls even slim ones, have abundant and shapely breasts, and others for instance, overweight have a disproportionately small breasts. Until now, the only effective way to enlarge the size of the bust were extremely expensive and very painful plastic surgeries, which most women who even were in a good financial situation could not afford.
Fortunately, thanks to the medicine development there appears a chance for all those women who are not satisfied with their breasts. We are talking about modern supplements- thanks a unique formula they stimulate breast growth effectively and safely. On the market there are dozens of products. We want to help you in choosing the right ones which are the most popular among users and have the best opinions. You can check the products in the ranking.
1Breast Fast
Breast Fast - Created by women for women
- Effectiveness:
- The speed of the action:
- Sustainability of results:
- Safety:
Complete your daily diet applying Breast Fast, which is not without reason at the top of our ranking. Thousands of women all over the world confirm that it is a supplement which not only effectively enlarges breasts, but it also makes the girls much more self-confident.
Thanks to Breast Fast you will gain not only bigger and fuller breasts, but it will also become firmer and nipples will be more sensitive. The pleasure of touching them will be increased and you and your partner will be satisfied.More information about Breast Fast >>
2Breast Success
BreastSuccess - use the power of estrogen
- Effectiveness:
- The speed of the action:
- Sustainability of results:
- Safety:
BreastSuccess is one of the first supplements which stimulates the growth of breasts tissue effectively and enlarge breast size. It works is based on a natural formula made of unique composition of herbs which increase the production of estrogen, what is responsible for the size of the female breast.
BreastSuccess as first product has achieved marketing success thanks to its high efficiency and all new products are inspired by it for many years.More information about Breast Success >>
Brestrogen - enlargement breasts cream
- Effectiveness:
- The speed of the action:
- Sustainability of results:
- Safety:
Brestrogen is the only non-supplement in our ranking, and at the same time it is the most effective product for breast enlargement among creams and gels. In contrast to oral supplements, it is put directly to breast skin so all ingredients are directly absorbed through the skin and go straight to the breast tissues and stimulate their growth.
The application of the cream on the skin is fast and easy. The cream is odorless and absorbs quickly so you it does not leave any marks on clothes.More information about Brestrogen >>
I was on the English course and I fell in love with the boy who sat next to me. Unfortunately, he was still staring at the breasts of our teacher and he almost did not notice me. Then I decided to do something to enlarge the size of my bust. I chose BreastFast and despite initial doubts, today I cannot stop boasting about it. My breasts enlarged two sizes and I catch all the time some handsome guys who stars at me.Magda recommends
Breast Fast
I do not know what was wrong with me. I was 30 years old, overweight, gave birth to two children, and my breasts were still small. I wanted to have a plastic surgery, but two children is a big expense and although my husband earns very well, still there is said much about the crisis. My friend recommended me BreastSuccess and I decided to use it. After two months, my breasts had enlarged considerably, and my husband cannot stop play with them.Kasia recommends
Breast Success
I would like only say that Breast Fast work! Now I am an owner of beautiful breasts, and I am glad that all my old bras are thrown away. I have never felt so confident in my body. When I see other women's envious glances I want to scream with joy!Ania recommends
Breast Fast


text:
"Amazing hosts. Responsive, clear and most importantly they had a wonderful time with Charlie, gave..."
"This was Silo's second stay wil Allana and she has been excellent. Silo was really happy to see her ..."
"Catherine was very nice and easy to deal with. Our dog Archie loved her."
"We have come home to 2 very happy dogs. Hoping we can use Hannah again. One of our dogs is old and..."
"Thanks for everything! You are wonderful!"
"Alena was great with my little boy. Would definitely approach her again next time I'm away. "
"We had to reluctantly leave our puppy after he'd had surgery the week before. Jo was so..."
"Connie and her pet Mimo looked after Roxy very well. She asked how I did things back home, so she..."
"Our holiday care for Scooter fell through last minute. On stumbling upon Madpaws, Vicky was quick..."
"Louisa, was great! she was so easy to meet with and stayed for extra cuddles with my boys when she..."
Pet sitting in Carlingford . Pet boarding alternative to kennels in Carlingford . Find a trusted pet sitter in Carlingford , New South Wales . We verify our pet sitters and the stay of your dog or cat is insured.


text:
New Year will be to increase your individual some of fashionable on the mens christian louboutin.
I enjoy beautiful cheap christian louboutin shoes, because women's high heel sandals can make my family feel trend.
You're interested in style trends cheap christian louboutins? Check it out Currently!
National Catholic Register
Copyright © 2016 EWTN News, Inc. All rights reserved.
Reproduction of material from this website without written permission is strictly prohibited.
Unlicensed commercial use or monetization of National Catholic Register RSS feeds is strictly prohibited.
Accessed from 22.214.171.124


text:
Course Overview
The course has been designed to give you the fundamental skills needed if you're new to beginning developing iOS and OS X applications. The Objective-C for Beginners course also covers the basics of ANSI C as well as the Objective-C language, which is the cornerstone of iOS development.
Our smaller class size will help ensure that you get all your questions answered. All our development courses are taught by developers who have developed real world iOS apps.
There are no specific prerequisites for attending this course, but if you're in any doubt about your suitability for this course, please call our training pros on 020 8645 5806 who will be pleased to discuss your training needs in more detail.
Who should take Beginning Objective-C Development
- Anyone wanting to learn how to develop iOS Apps using Objective-C
- Developers with no prior experience developing iOS apps
- Anyone interested in learning Objective-C and the Foundation Framework to develop code for the iPhone or Mac OS X desktop apps


text:
Locanda Ca' del Console
No prices found through our partners. Please contact the business directly or check some of our recommended alternatives.
How has this inn rated in the past?
Travelers also recommend:
TripAdvisor Reviews Locanda Ca' del Console Venice
Travel Blogs from Venice
Bologna to Venice
... standing by the door. They had a menu of the day that wasn't too dear so we both had pasta starters, after which Sean had a chicken fillet and I risked the Venetian liver which was really nice. Adding in Sean's beer, some water and the bread that appears automatically as soon as you sit down just about doubled the bill but it was still not bad. Our shopping was cut short by a thunderstorm that sent us back to our room for a while. It made for some very ...
You get that sinking feeling.
... very comfortable. We had an hour and 1/2 to spare, before we had to leave Milan for Venice, so we decided to have breakfast at a small caf� in the station. I also had to find the WC. It took me ages, but I finally got there, only find that I had no money to get in! Back to the caf�, to get some money. I made it, just in time!
Finally, we caught our train. The train was very long and packed solid. Venice must be popular. The ...
Planes, Trains and Automobiles.....and Vaporettos!
... the Royal San Marco hotel IS actually on San Marco but it makes so many turns and is called other street names it's no wonder they couldn't find it! And indeed it is a stones throw from the piazza, for it we had gone down a different alleyway we could have only had to go about a block and a half! Once settled in at the hotel we went went to find dinner. In their quest to find the hotel Em and Kirk came upon a restaurant hidden back on a ...
Day one in Venice
... different shops but did not buy anything. Stop for coffee and get another Vaparetto back to the main island. Once back it is a day of walking and site seeing. We checked out some restaurants as suggested by out hotel and booked one for dinner. Also found a small wine store and bought some Lemoncgello both normal and creamy. From there it is off for a morning drink followed by pizza and icecream. ...
Bare shoulders equals floozy
... the pedestrian areas of Venice (the San Polo/San Croce neighborhoods). During my walk, I stopped for a coke light, I forgot how sweet Coke light is! So, I spent the day just wondering... Just me and the map and a Diet Coke...No where in mind: just taking it in. Along the way, I grabbed a slice of pizza and ate it as I walked. At this point I kind of picked up a tail... Or rather a pick pocket. As this is not my first rodeo, I ...


text:
The Center for Tire Research
The Center for Tire Research vision is to provide the forum for industry/university cooperative research on the further development, validation, and industrial implementation of the emerging technologies of tire materials, manufacturing, modeling, and testing.
The Center's cooperative program research projects are integrated into four (4) highly interdisciplinary research thrust areas that cover a broad spectrum of tire science and engineering. These are tire Materials, Modeling, Manufacturing, and Testing.
New Member: Maxxis Tire
Earlier this spring we welcomed Maxxis Tire as a member of CenTiRe. They have already become an active participant in the Center by taking part in the new project proposal assessment process and attending the Spring IAB meeting. We look forward to many years of interaction and involvement.


text:
Early in human history, individuals learned to exploit viagra cost us the fermentation process for beverages and tonics. SUMMARY Alcohol is a legal drug that is widely used in society for social and medical benefits. Alcohol is a sedative hypnotic and as such has euphoric disinhibitory effects and is widely used as a 'social lubricant'. Alcohol taken in excess also is one of the most toxic substances in society from the perspective of both behavioral and physical damage to the body.
Much of the alleged stimulant effects of alcohol probably result from its disinhibitory effects. Alcohol is readily derived in nature by the process of fermentation. As the dose of alcohol increases, disinhibition gives way to motor impairment, muscular incoordination, impairments in reaction time, impairments in judgment, impairments in sensory processing, and impairments in cognitive function—all behavioral effects that contribute to its behavioral toxicity.
A., Bolivar, V., 232 4. Abiola, O., Angel, J. ALCOHOL Alheid, G. A., Belknap, J. M., Avner, P., Bachmanov, A.
P., Blizard, D. Cell 75, 1273–1352. K., Bennett, B., Blankenhorn, E.
334(32):37171– 37178 viagra cost us. A novel human hepatic organic anion transporting polypeptide. The Role of Membrane Transport 193 161. J Biol viagra cost us Chem 1999. Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.
Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG.
Effects of vitamin viagra cost us E supplementation. Pirozhkov SV, Eskelson CD, Watson RR. 28:553–548. Chronic ethanol and cocaine-induced hepatotoxicity.


text:
Possible Answer
WebMD experts and contributors provide answers to: what is K/uL in platelet count? - read more
UL is a measure of volume. Get more information and details on the 'uL' measurement unit, including its symbol, category, and common conversions from uL to other ... - read more
Please vote if the answer you were given helped you or not, thats the best way to improve our algorithm. You can also submit an answer or search documents about k ul units meaning.


text:
Brewster Rockit by Tim Rickard
- January 19, 2013
- From Beginning
- Previous feature
- Next feature
- Current
Comments (15) (Please sign in to comment)
Can we give them Honey Boo Boo as collateral?
Uh, no … the purpose of collateral is to give the other side something you can't afford to lose.
Not something you hope they'll keep!
Some of the best comics ever!!!
Oh, Man, this is worse than Reagan at Reykjavik, givin' away the store…Never,….. NEVER EVER!! Give up the kittens on the Roomba…..If we are to be a free nation…or federation….or kinky club…. .
MAD, huh?……… What, me worry? As a teacher, I have to give credit to Mad Magazine for being the first step to questioning authority, an introduction to parody, sarcasm, and alternative view points…Oh, yeah,and there is the fact that it has always been funny as hell……
You Tube memberships for all.
Nuke 'em with reruns of Amish Mafia.
Uh, Reagan DIDN'T give away the store, or anything else. That's when the wheels started to come off the good ol' USSR.
re: jrmerm
and then the U.S. started becoming like them in 1993. Isn't becoming like the enemy losing?
It's ever-accelerating. In the last year alone, 9 of 10 Planks of the Communist Manifesto in the 2012 Democrat Platform, altering the election results in several thousand precincts when the results were not what they wanted on Nov. 6. 2012, executive orders being used as legislation, one breach of the Rule of Law after another, etc.
jrmern, when Reagan and Gobachev were negotiating alone, they both agreed to get rid of every single nuke in their arsenal imediately…….The state department wouldn't go along with the idea, for obvious reasons…So they brought in some professional negotiators….
Nabu, you're trippin' again, Seriously, dude, things ain't that bad! Lighten up, you're just scaring yourself into a tizzy….
I take it you refer to "pink people" in the same sense Bucky Katt refers to his owner as "pinkish." You and Bucky certainly have the same grasp on reality.
Or Reagan giving into the Iranian hostage takers, by trading missiles for them…One hostage = 20 missiles….Reaganomics…
Beer, are you drinking some sort of psychedelic brew? I'd taste some, but it seems to give you bad trips….Think like a balloon, not a rocket…..
cost of ISBM $75,000,00 each. Americans are expensive. Or did he swap the discount $10K missiles?
Anywho, the only reason the guys w/pointey ears are at the table is that we make better time wasteing videos than they do.
Bwahahahah, have another annoying orange you bad apples.
- Refresh Comments.
You must be signed in to make a comment.


text:
Our online tools make booking, managing your schedule and paying for lessons easy and hassle-free.
Easily search and compare teachers in your area, including past student reviews and background checks.
If you're not completely satisfied, we'll help you find a new teacher or refund any unused lesson credits.
I tailor all my lessons to the individual students interests and wants.
Whatever your goals are, I'll help you get there.
I studied under some great songwriters in college and post college.
I have been teaching songwriting/composition since 1989
Students will have the ability to read and write musical notation fluently.
Students may work on whatever kinds of projects are of most interest to them. These could include writing pop songs; writing music for a school band, orchestra, or small ensemble; or writing music for themselves and/or their friends to play. Students are free to write in whatever genre/style they would like. I will work on how to notate musical ideas, how to structure a piece of music, and where to find inspiration, but the instruction will be more tailored to the student's specific needs. As with private instrumental lessons, students will be expected to work on their craft during the week.
Have you ever written a poem and not known how to write music to it? Well I can help you with that! Or have you ever had a melody in your head not knowing how to put it down on paper? I can help you with that too! There's no basic trick to writing songs but I can help you develop your ideas and inspirations into a real song! Can't wait to get started!
I enjoy songwriting and dabble in it as often as possible! My theory knowledge gives me an edge, and I can definitely explore your songwriting capabilities with you.
Compare hundreds of teachers based on the criteria that matter to you, including background checks, age and experience.
When you've found the perfect match, schedule your lessons online using the teacher's real-time availability.
Your teacher will welcome you with a personalized curriculum to meet your specific goals and you'll be able to manage your entire schedule through our free online account.
Zero travel time is great for a busy schedule.
Typically priced lower than local lessons.
Online students stick with lessons as long as local students.
Take your voice to the next level. Download free video tutorials to start singing like the star you are!
Getting Started with Music Lessons guides you through selecting a teacher & preparing for your first lesson.
Kickstart your guitar playing. Download free video tutorials to learn about chord progressions, strumming, and more!


text:
As a neurologist in Houston, TX, Dr. Flavia Nelson works with patients who have issues related to the nervous system, like epilepsy or ALS.
We invite you to write a review about your experience with Dr. Nelson.
Find potential causes and treatment options with the MD.com Symptom Checker.
See our Privacy Policy and Terms of Use.


text:
Welcome to World Academy of Tirana
The World Academy of Tirana (WAT) is an international school in the capital of Albania that offers the International Baccalaureate (IB) Programme. WAT is an IB World School (IB school code: 006795).
WAT is authorized to provide the IB Primary Years Programme (PYP) (ages 5-11). After completion of the PYP Programme, WAT students continue to our IB Middle Yeas Programme (MYP) (ages 11-15). WAT is a candidate school for the IB Middle Years Programme (MYP). Furthermore, WAT will soon pursue the IB Diploma Programme (DP) candidate status (ages 16-18).
WAT is recognized for its wonderful balance of learning through discovery, with academic rigor introduced gradually at the right age and stage. WAT is the only international school in Albania to offer an internationally recognized programme such as the International Baccalaureate (IB) programme leading to a globally accepted qualification. At WAT, children from the expat and local communities mix naturally to create a truly cosmopolitan, intellectual and English learning environment. Language support is available for non-English speaking attending children. The school is exceptionally well resourced and offers a focused, inquiry-based international education through maintaining the highest standards, quality and integrity.
"International Baccalaureate (IB) World Schools share a common philosophy – a commitment to high quality, challenging, international education that we believe is important for our students. Only Schools authorized by the IB Organization can offer any of its three academic programmes: the Primary Years Programme (PYP), the Middle Years Programme (MYP), or the Diploma Programme (and in addition the IB Career-related Certificate). Candidate status gives no guarantee that authorization will be granted."
WAT Spotlight
MYP students visiting the City Hall
WAT News
DP - consultancy vis Sep/30/2016
We just completed our IBDP consu
Earth Day 2016 Apr/22/2016
At WAT, we celebrate Earth Day e
Grade 10 Field Trip Mar/11/2016
Grade 10 are studying Waves, Vib
WAT Event Calendar
First day of school 8.20 - 12.00
Back to school day 9.30 - 11.30
100 days of School (Primary) 08.30 - 15.30
WAT Featuring Videos
Matea, our Gr. 8 student


text:
Cataracts cannot be removed with a laser, only through a surgical incision or a cataract surgery. There are laser devices for cataract removal under investigation, but none are approved by the Food and Drug Administration.
In cataract surgery, the cloudy lens is removed from the eye. In most cases, the focusing power of the natural lens is restored by replacing it with a permanent intraocular lens implant.
Nearly all cataracts today are removed by extra-capsular cataract surgery, in which the posterior capsule of the natural lens is left in place to support the plastic replacement lens which is implanted at the time of the cataract surgery.
Both "one-stitch" and "no-stitch" surgery are just variants of phacoemulsification. The incision used in the surgery may be placed in one of several locations and the architecture of the incision may vary as well. The same incision may be "no-stitch" if the incision is watertight following cataract surgery, or "one-stitch" if it is not, and requires a stitch to make it so.
For more info, please login to http://roshaneyecare.com/index.aspx
Know the five types of psoriasis and how to spot flares.
Newer diabetes treatments can suppress appetite and aid weight loss.
Try these tips to get your salivary glands back into action.
Constipation is a common side effect of opioid and narcotic pain medicines.
Is it sensitive skin or something else?


text:
18. cheap cialis canada Does the magnitude of hyperamylasemia or hyperlipasemia correlate with the severity of AP?. The levels should be greater than 880 mg/dL, to consider hypertriglyceridemia as a cause of AP. It is unclear if diluting the cheap cialis canada serum sample allows for true values of serum amylase, but when performed, there may be an elevated reading.
No, the levels of amylase and/or lipase do not correlate with the severity of AP or its prognosis. 19. What is the most reliable serum marker for diagnosing biliary AP?.
Involvement of the amygdala in stimulus-reward cheap cialis canada associations. Interaction with the ventral striatum. Neuroscience 27, 57–76.
Cador, M., Robbins, T. (1988). W., and Everitt, B.
K., Nelson, cheap cialis canada D. H. D., Collison, E. Chisholm, C. Elsevier.
Electroencephalography and Clinical Neurophysiology, 15, 878–898. R., & Cordell, W. Electroencephalography in Neuroergonomics 28 EEG activity. (2000).
Control of cocaine-seeking behavior by drug-associated stimuli in rats cheap cialis canada. H., Kerr, T. L., and Ben-Shahar, O. 3514–3575, journal of Neuroscience 15. Weiss, F., Maldonado-Vlaar, C.
The patient remains cheap cialis canada asymptomatic, more typically. However, the esophagus has an extensive blood supply, and contractions are unlikely to be sufficiently prolonged to induce ischemia. Rather, it may represent an epiphenomenon that, like pain, is induced by another, unrecognized process. This emphasizes that cheap cialis canada simply diagnosing an esophageal motility disorder does not prove that it is the cause of the patient's pain.
Occasionally, during routine manometry, a patient develops pain coincident with abnormal waveforms, demonstrating a closer link between the dysmotility and the pain. It is also possible that dysmotility per se is not the cause of pain.
''False'' or cheap cialis canada ''not true'' cellulite is characterized by flabby tissues, in excess and not adherent to the deep planes, with scarce muscular tonicity. This situation does not require treatment but only electric stimulations or exercise. Because the pathological picture is reported as a structural state, we believe that this classification is not exact. 4). Our BIMED–TCD & 187 Clinical aspects 1, rather.


text:
pasteTo copy an object from a buffer (or clipboard) to a file. In word processing, blocks of text are moved from one place to another by cutting and pasting. When you cut a block of text, the word processor removes the block from your file and places it in a temporary holding area (a buffer). You can then paste the material in the buffer somewhere else.
Modern operating systems, such as Microsoft Windows, allow you to cut an object from one application and paste it into another. Depending on how the object is pasted, it can be either linked or embedded.
Stay up to date on the latest developments in Internet terminology with a free weekly newsletter from Webopedia. Join to subscribe now.
Webopedia's student apps roundup will help you to better organize your class schedule and stay on top of assignments and homework. Read More »List of Free Shorten URL Services
A URL shortener is a way to make a long Web address shorter. Try this list of free services. Read More »Top 10 Tech Terms of 2015
The most popular Webopedia definitions of 2015. Read More »
Java is a high-level programming language. This guide describes the basics of Java, providing an overview of syntax, variables, data types and... Read More »Java Basics, Part 2
This second Study Guide describes the basics of Java, providing an overview of operators, modifiers and control Structures. Read More »The 7 Layers of the OSI Model
The Open System Interconnection (OSI) model defines a networking framework to implement protocols in seven layers. Use this handy guide to compare... Read More »


text:
New head for Welsh sports department
Dr Joanne Thatcher has been appointed Head of the Department of Sport and Exercise Science at Aberystwyth University.
A graduate of Bangor University, Dr Joanne Thatcher received a PhD in Developmental Sport Psychology, also from Bangor University.
An Associate Fellow of the British Psychological Society and Chartered Psychologist, Dr Thatcher is a past chair of our Division of Sport and Exercise Psychology and the current Chair of the Society Qualification in Sport & Exercise Psychology Board.
Dr Thatcher has taught in sport and exercise science since 1996 and has acted as sport psychology consultant to athletes from a range of sports, including those at international standard. She has published research in international and national journals, co-edited the second edition of Coping and Emotion in Sport, published by Routledge, and co-authored the following books: Sport and Exercise Science, Sport and Exercise Psychology (Learning Matters) and Sport Psychology (Palgrave Macmillan).
Her research interests include psychophysiological and affective responses to exercise and competitive stress, and exercise motivation in clinical and non-clinical populations.
Dr Thatcher told this website: "I'm delighted to be appointed as Head of the Department of Sport and Exercise Science at Aberystwyth University. This is a very exciting time here with a number of changes, challenges and developments, not least closer working between sport and exercise science and our department of Psychology, which of course opens up lots of opportunities for us both to advance in the field."


text:
Capcom: No visible alternate SSFIV costumes is Sony's fault
If you've spent a lot of money on adding extra costumes for your favourite characters on Super Street Fighter IV to show off to your mates then you might want to reconsider your purchases.
Apparently, while the alternate costumes are available to buy on PSN they are not visible to other players who have not also bought the same costume packs unlike on the Xbox 360. According to Capcom's Seth Killian this is down to Sony refusing to cover the cost of distributing the costumes to all players for visibility not just those that bought the packs.
Killian wrote in a post on Capcom's official forums: "The DLC for the newest costumes is additional data that must be put on your machines from the first-party networks (XBL and PSN). When you add new data to an existing product, there are significant costs to do so charged by the first parties. On XBL, those costs were covered by Microsoft. As a result, the data is distributed to everyone, so even if you have not bought the new costumes, you can still see them if youre fighting against someone that has because you still received the new data required to display them."
He continued: "For Sony, those significant costs are not covered. As a result, you only get the new costume data when you actually buy the costumes. Those that dont buy the costumes cant see them, because the new costume data isnt present on your machine, and so you only see costumes you already have the data to represent. The story is a bit more complicated because the costs of adding new data vary by region in some cases, and some additions are free, or free within a certain timeframe, etc., but the bottom line in this particular case is that Sony would [have] charged Capcom significant fees for distributing the new costume data to users that hadnt actually bought the DLC. Microsoft covered those costs, so the costume data is visible to all there."
Latest News
- Call of Duty: Black Ops III is coming to the PS3 and Xbox 360 after all
- Tomonobu Itagaki's Devil's Third gets a release date
- Adr1ft is coming to PC and consoles at the end of the summer
- EA gives the new Mirror's Edge a name – Mirror's Edge Catalyst
- ZombiU PS4 and Xbox One port reportedly in the works
- Mike Bithell's Volume to be released this August
- Gearbox's new shooter Battleborn gets a pre-E3 trailer
- Steam Controller launches in October, Steam Machines arrive in November
- Gears Of War devs Black Tusk change their name to The Coalition ahead of E3


text:
Noble Shower Pro Slope
Noble Shower Pro Slope
Creates correct slope under heavy waterproofing membrane - a sheet membrane like Chloraloy must be installed over Pro-Slope
No mortar, mixing, or curing to create slope
Light and easy to cut
Noble Shower Pro Slope
- Durable non-deteriorating EPS preformed composite
- Rated at 500 lbs. per square foot
- Available in 3 sizes and 4 extensions
- Extend or trim to fit shower configuration - light and easy to cut
- Install under a sheet membrane like Chloraloy
- Designed for use with heavy membranes and clamping drains
REQUIRES reinforced mortar bed installed over Pro-Slope/sheet membrane (generally a 1-1/4" thick mixture of a 1:4 mix of portland cement to sand)
Pro Slope Sizes
Pro-Slope Standard
40" x 40",
thickness 1/8" to 1"
60" x 60",
thickness 1/8" to 1-1/4"
Pro-Slope Tub Replacement
40" x 80" Tub Replacement,
thickness 1/8" to 1-7/8"
Available Extensions
Pro-Slope Flat Extensions
20" x 40" Flat,
thickness 1"
30" x 60" Flat,
thickness 1-1/4"
Pro-Slope Tapered Extensions
20" x 40" Tapered
thickness 1" to 1-7/16"
30" x 60" Tapered
thickness 1-1/4" to 1-7/8"
Keywords: 210, adjust, angle, bathroom, corner, correct, deep, floor, inch, inches, noble, preformed, preslope, proslope, prosourcecenter-com, rectangular, shallow, shower, slope, spa, square, tile, tiled, waterproof, waterproofing, watertight, kerdi shower kits - waterproofing, shower pans kerdi shower kits - waterproofing, waterproofing accessories other, noble company, Noble, Shower, Slope, Creates, under, heavy, membrane, sheet, Chloraloy, installed, mortar, mixing, curing, create, Light
Description: Noble Shower Pro Slope. Creates correct slope under heavy waterproofing membrane - a sheet membrane like Chloraloy must be installed over Pro-Slope. No mortar, mixing, or curing to create slope. Light and easy to cut.
Categories: Kerdi Shower Kits - Waterproofing > Shower Pans; Kerdi Shower Kits - Waterproofing > Waterproofing Accessories Other
Google Category: Hardware > Plumbing > Plumbing Fixtures > Shower > Shower Bases
SKU(s): 176270, 176271, 176272, 176273, 176274, 176275, 269273
MPN(s): 210, 213, 212, 2121, 2131, 2132, 2135